Product NDC: | 0228-2530 |
Proprietary Name: | Nifedipine |
Non Proprietary Name: | Nifedipine |
Active Ingredient(s): | 20 mg/1 & nbsp; Nifedipine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-2530 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072556 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070102 |
Package NDC: | 0228-2530-10 |
Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0228-2530-10) |
NDC Code | 0228-2530-10 |
Proprietary Name | Nifedipine |
Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0228-2530-10) |
Product NDC | 0228-2530 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nifedipine |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20070102 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | NIFEDIPINE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |